These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 6780051)

  • 1. Levodopa: long-term impact on Parkinson's disease.
    Br Med J (Clin Res Ed); 1981 Feb; 282(6262):417-8. PubMed ID: 6780051
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hallucinations in Parkinson's disease].
    Moser A; Hagenah J; Kömpf D
    Nervenarzt; 2003 Apr; 74(4):376-85, quiz 385-6. PubMed ID: 12707709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levodopa-induced psychosis: a kindling phenomenon.
    Moskovitz C; Moses H; Klawans HL
    Am J Psychiatry; 1978 Jun; 135(6):669-75. PubMed ID: 655276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dream phenomena induced by chronic levodopa therapy.
    Sharf B; Moskovitz C; Lupton MD; Klawans HL
    J Neural Transm; 1978; 43(2):143-51. PubMed ID: 104005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of drug-induced psychosis in Parkinson's disease with clozapine.
    Greene P; Cote L; Fahn S
    Adv Neurol; 1993; 60():703-6. PubMed ID: 8420214
    [No Abstract]   [Full Text] [Related]  

  • 6. Motor complications associated with chronic levodopa therapy in Parkinson's disease.
    Obeso JA; Grandas F; Vaamonde J; Luquin MR; Artieda J; Lera G; Rodriguez ME; Martinez-Lage JM
    Neurology; 1989 Nov; 39(11 Suppl 2):11-9. PubMed ID: 2685647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychiatric aspects of L-dopa therapy of Parkinson's disease.
    Pearlman CA; Sax DS; Feldman RD
    Psychiatry Med; 1972 Jan; 3(1):45-50. PubMed ID: 4679766
    [No Abstract]   [Full Text] [Related]  

  • 8. Ziprasidone for drug-induced psychotic symptoms in Parkinson's Disease.
    Duggal HS; Singh I
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):583-4. PubMed ID: 18022304
    [No Abstract]   [Full Text] [Related]  

  • 9. Behavioral indicators of hallucinosis in levodopa-treated Parkinson's disease.
    Glantz RH; Bieliauskas L; Paleologos N
    Adv Neurol; 1987; 45():417-20. PubMed ID: 3825719
    [No Abstract]   [Full Text] [Related]  

  • 10. Involvement of serotonin in clinical features of Parkinson's disease and complications of L-DOPA therapy.
    Melamed E; Zoldan J; Friedberg G; Ziv I; Weizmann A
    Adv Neurol; 1996; 69():545-50. PubMed ID: 8615179
    [No Abstract]   [Full Text] [Related]  

  • 11. [Acute psychotic status after sudden interruption of treatment of Parkinsonism with levodopa].
    Ledić P; Sepcić J; Antoncić N
    Neurologija; 1977; 25(1-2):95-7. PubMed ID: 616879
    [No Abstract]   [Full Text] [Related]  

  • 12. What to do when Sinemet fails: Part one.
    Klawans HL
    Clin Neuropharmacol; 1984; 7(2):121-33. PubMed ID: 6733692
    [No Abstract]   [Full Text] [Related]  

  • 13. Ziprasidone in Parkinson's disease psychosis.
    Connemann BJ; Schönfeldt-Lecuona C
    Can J Psychiatry; 2004 Jan; 49(1):73. PubMed ID: 14763682
    [No Abstract]   [Full Text] [Related]  

  • 14. Zotepine in levodopa-induced Psychosis.
    Spieker S; Stetter F; Klockgether T
    Mov Disord; 1995 Nov; 10(6):795-7. PubMed ID: 8750001
    [No Abstract]   [Full Text] [Related]  

  • 15. Cerebral atrophy and long-term response to levodopa in Parkinson's disease.
    Schneider E; Fischer PA; Jacobi P; Becker H; Beyer M
    J Neurol; 1979; 222(1):37-43. PubMed ID: 93625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parkinson's disease in 1984: an update.
    Lang AE; Blair RD
    Can Med Assoc J; 1984 Nov; 131(9):1031-7. PubMed ID: 6388779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behavioral alterations and the therapy of parkinsonism.
    Klawans HL
    Clin Neuropharmacol; 1982; 5 Suppl 1():S29-37. PubMed ID: 7116345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopaminergic hallucinosis with fluoxetine in Parkinson's disease.
    Lauterbach EC
    Am J Psychiatry; 1993 Nov; 150(11):1750. PubMed ID: 8214188
    [No Abstract]   [Full Text] [Related]  

  • 19. [Exogenous psychoses in Parkinson syndrome. Frequency and causal conditions].
    Schneider E; Fischer PA; Jacobi P; Grotz A
    Fortschr Neurol Psychiatr; 1984 Jun; 52(6):207-14. PubMed ID: 6745832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cenesthetic hallucinations in a patient with Parkinson's disease.
    Jiménez-Jiménez FJ; Ortí-Pareja M; Gasalla T; Tallón-Barranco A; Cabrera-Valdivia F; Fernández-Lliria A
    J Neurol Neurosurg Psychiatry; 1997 Jul; 63(1):120. PubMed ID: 9221983
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.